RENALYTIX PLC LS-0025 - Asset Resilience Ratio
RENALYTIX PLC LS-0025 (2O9) has an Asset Resilience Ratio of 1.01% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 2O9 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how RENALYTIX PLC LS-0025's Asset Resilience Ratio has changed over time. See how financially flexible is RENALYTIX PLC LS-0025 to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down RENALYTIX PLC LS-0025's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see RENALYTIX PLC LS-0025 asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €100.00K | 1.01% |
| Total Liquid Assets | €100.00K | 1.01% |
Asset Resilience Insights
- Limited Liquidity: RENALYTIX PLC LS-0025 maintains only 1.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
RENALYTIX PLC LS-0025 Industry Peers by Asset Resilience Ratio
Compare RENALYTIX PLC LS-0025's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638 |
Health Information Services | 0.49% |
|
Reliq Health Technologies Inc
V:RHT |
Health Information Services | 0.45% |
|
Diagnos Inc
V:ADK |
Health Information Services | 21.04% |
|
Careteq Ltd
AU:CTQ |
Health Information Services | 0.00% |
|
Oakridge International Ltd
AU:OAK |
Health Information Services | 2.92% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 17.07% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 32.70% |
Annual Asset Resilience Ratio for RENALYTIX PLC LS-0025 (2022–2025)
The table below shows the annual Asset Resilience Ratio data for RENALYTIX PLC LS-0025.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 1.64% | €100.00K ≈ $116.91K |
€6.10 Million ≈ $7.13 Million |
-8.22pp |
| 2024-06-30 | 9.86% | €700.00K ≈ $818.37K |
€7.10 Million ≈ $8.30 Million |
+4.38pp |
| 2022-06-30 | 5.48% | €2.74 Million ≈ $3.21 Million |
€50.06 Million ≈ $58.53 Million |
-- |
About RENALYTIX PLC LS-0025
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from … Read more